Furthermore, the SeNP treatment was found to promote apoptosis in cancer cells via regulation of apoptotic proteins, such as the caspase family, p53, and ROS, thus inhibiting the malignant tumor [60, 61]. The gene discussed is TP53; the disease is cancer.